Targeting the mevalonate pathway is a novel therapeutic approach to inhibit oncogenic FoxM1 transcription factor in human hepatocellular carcinoma
2007 ◽
Vol 16
(12)
◽
pp. 1023-1031
◽
2000 ◽
Vol 2
(2)
◽
pp. 117-127
◽
2014 ◽
Vol 210
(8)
◽
pp. 477-481
◽
1999 ◽
Vol 45
(3)
◽
pp. 299
2003 ◽
Vol 27
(4)
◽
pp. 289-301
◽